Introduction Identification of clinical characteristics associated with prognosis for idiopathic
pulmonary fibrosis (IPF) may help to guide management decisions. This analysis utilized …

Objective The association between nutritional status and prognosis of idiopathic pulmonary
fibrosis (IPF) remains unclear. This systematic review and meta-analysis aimed to explore …

Background Nintedanib is an approved therapy for idiopathic pulmonary fibrosis (IPF). Some
patients treated with nintedanib experience weight loss. Exploratory data suggest that low …

Association between body mass index (BMI) and prognosis in patients with idiopathic
pulmonary fibrosis (IPF) remains uncertain. We investigated the association between BMI …

The identification of novel prognostic biomarkers might enhance individualized
management strategies in patients with idiopathic pulmonary fibrosis (IPF). Although several …

Background Lower body mass index (BMI) and weight loss have been associated with
worse outcomes in some studies in patients with pulmonary fibrosis. We analyzed outcomes …

Purpose In the past few years, there has been a notable rise in the incidence and
prevalence of idiopathic pulmonary fibrosis (IPF) on a global scale. A considerable body of …

Aim: It has been reported that a high body mass index (BMI) is associated with better
survival in patients with idiopathic pulmonary fibrosis (IPF). We aimed to find out whether …

Rationale Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung
disease that has no cure. Many current research efforts center on diagnostic and therapeutic …

Background The processes that result in progression of idiopathic pulmonary fibrosis (IPF)
remain enigmatic. Moreover, the course of this disease can be highly variable and difficult to …